1-anilino-8-naphthalenesulfonate has been researched along with Dermatitis Medicamentosa in 2 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Excerpt | Relevance | Reference |
---|---|---|
"Sorafenib (Nexavar) is an oral multi-kinase inhibitor that targets tumor growth and angiogenesis." | 2.73 | Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma. ( Akaza, H; Murai, M; Naito, S; Nakajima, K; Tsukamoto, T, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Téllez Villajos, L | 1 |
Rodríguez de Santiago, E | 1 |
Aicart Ramos, M | 1 |
Cuño Roldán, JL | 1 |
Moreira Vicente, V | 1 |
Albillos Martínez, A | 1 |
Akaza, H | 1 |
Tsukamoto, T | 1 |
Murai, M | 1 |
Nakajima, K | 1 |
Naito, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase II Study of BAY 43-9006 in Japanese Patients With Renal Cell Carcinoma[NCT00661375] | Phase 2 | 131 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for 1-anilino-8-naphthalenesulfonate and Dermatitis Medicamentosa
Article | Year |
---|---|
Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Benzenesulfonates; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Di | 2007 |
1 other study available for 1-anilino-8-naphthalenesulfonate and Dermatitis Medicamentosa
Article | Year |
---|---|
[Elevation of pancreatic enzymes and facial edema. DRESS syndrome].
Topics: Adrenal Cortex Hormones; Amylases; Atorvastatin; Drug Eruptions; Drug Hypersensitivity Syndrome; Ede | 2015 |